搜索筛选:
搜索耗时5.7498秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
类      型:
[会议论文] 作者:LEI He-ping,ZHONG Shi-long,WU Hong,LIN Hao-ming,Li Xin-xin,ZHANG Zhi-wei,MAI Li-ping,HE Gou-dong,WANG Xi-pei, 来源:中国药理学会第十四次全国学术大会暨施维雅优秀青年药理学工作者奖20周年学术论坛 年份:2016
  OBJECTIVE Genetic variants in the pharmacokinetic (PK) mechanism are the main underlying factors that modify the antiplatelet efficacy of clopidogrel....
[期刊论文] 作者:,LIN Hao-ming,ZHANG Bin,ZHANG Zhi-wei,MA Dun-liang,SUN Shuo,LI Han-ping,MAI Li-ping,HE Gou-dong,WANG Xi-pei, 来源:中国药理学与毒理学杂志 年份:2016
OBJECTIVE Genetic variants in the pharmacokinetic(PK)mechanism are the main underlying factors that modify the antiplatelet efficacy of clopidogrel.Hence,joint...
[会议论文] 作者:ZHONG Shi-long,LI Han-ping,HE Gou-dong,WANG Xi-pei,YU Xi-yong,ZHOU Huang-kai,TANG Lan,LIU Shu-wen,TANG, 来源:中国药理学会第十三次全国学术大会 年份:2015
Aim Clopidogrel therapy is associated with a substantial variability in pharmacokinetics (PK) and pharmacodynamics (PD) responses.To date, known gene variants explain only a small proportion of the va...
[会议论文] 作者:,LIN Hao-ming,ZHANG Bin,ZHANG Zhi-wei,MA Dun-liang,SUN Shuo,LI Han-ping,MAI Li-ping,HE Gou-dong,WANG Xi-pei, 来源:中国药理学会第十四次全国学术大会暨施维雅优秀青年药理学工作者奖20周年学术论坛 年份:2016
OBJECTIVE Genetic variants in the pharmacokinetic (PK) mechanism are the main underlying factors that modify the antiplatelet efficacy of clopidogrel....
相关搜索: